The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy
- PMID: 33476912
- DOI: 10.1016/j.ejcb.2021.151153
The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy
Abstract
Tumour-associated macrophages (TAMs) that present abundantly in the tumour microenvironment (TME) exhibit a protumour property, such as promoting genetic instability, tumour metastasis and immunosuppression. Macrophage-targeted therapeutic approaches hence have been applied and shown their significances in the process of tumour immune treatment, including blocking TAM recruitment, depleting or transforming TAMs that already exist in the tumour site. Here, we summarized the functional regulation of TAMs in the respects of hypoxia environment, metabolism in the tumour microenvironment and the transcription factors involved. We reviewed the strategies for transforming TAMs, including immune stimuli targeting TAMs, inhibitors against TAMs, pathogen or irradiation stimulation on TAMs, and the application of natural compounds in TAMs. Furthermore, we also discussed the macrophage-targeted therapies in the clinical studies. Taken together, this review tries to shed light on the TAM regulation and the main strategies of TAM reprogramming for an enhanced immune surveillance.
Keywords: Immunotherapy; TAM transformation; TME; Tumour.
Copyright © 2021 The Authors. Published by Elsevier GmbH.. All rights reserved.
Similar articles
-
Molecular Repolarisation of Tumour-Associated Macrophages.Molecules. 2018 Dec 20;24(1):9. doi: 10.3390/molecules24010009. Molecules. 2018. PMID: 30577495 Free PMC article. Review.
-
Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.Immunol Res. 2022 Aug;70(4):432-440. doi: 10.1007/s12026-022-09277-w. Epub 2022 Apr 29. Immunol Res. 2022. PMID: 35486115 Review.
-
Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy.J Hematol Oncol. 2024 Jun 11;17(1):44. doi: 10.1186/s13045-024-01559-0. J Hematol Oncol. 2024. PMID: 38863020 Free PMC article. Review.
-
Targeting tumor-associated macrophages for cancer immunotherapy.Int Rev Cell Mol Biol. 2022;368:61-108. doi: 10.1016/bs.ircmb.2022.02.002. Epub 2022 Apr 27. Int Rev Cell Mol Biol. 2022. PMID: 35636930
-
Macrophage targeting in cancer.Ann N Y Acad Sci. 2021 Sep;1499(1):18-41. doi: 10.1111/nyas.14377. Epub 2020 May 22. Ann N Y Acad Sci. 2021. PMID: 32445205 Review.
Cited by
-
Chamaejasmenin B, an Inhibitor for Metastatic Outgrowth, Reversed M2-Dominant Macrophage Polarization in Breast Tumor Microenvironment.Front Immunol. 2021 Dec 28;12:774230. doi: 10.3389/fimmu.2021.774230. eCollection 2021. Front Immunol. 2021. PMID: 35027915 Free PMC article.
-
Emerging Innate Immune Cells in Cancer Immunotherapy: Promises and Challenges.BioDrugs. 2024 Jul;38(4):499-509. doi: 10.1007/s40259-024-00657-2. Epub 2024 May 3. BioDrugs. 2024. PMID: 38700835 Free PMC article. Review.
-
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond.Biomark Res. 2024 Aug 23;12(1):86. doi: 10.1186/s40364-024-00637-2. Biomark Res. 2024. PMID: 39175095 Free PMC article. Review.
-
Outer Membrane Vesicles Coating Nano-Glycyrrhizic Acid Confers Protection Against Borderella bronchiseptica Through Th1/Th2/Th17 Responses.Int J Nanomedicine. 2022 Feb 11;17:647-663. doi: 10.2147/IJN.S350846. eCollection 2022. Int J Nanomedicine. 2022. PMID: 35177904 Free PMC article.
-
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma.Cancers (Basel). 2024 Jun 11;16(12):2191. doi: 10.3390/cancers16122191. Cancers (Basel). 2024. PMID: 38927897 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical